Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Source: SeekingAlpha
2025-06-06 17:26:17 ET
...
Read the full article on Seeking Alpha
For further details see:
Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Akebia Therapeutics Inc.
NASDAQ: AKBA
AKBA Trading
-3.94% G/L:
$1.34 Last:
787,551 Volume:
$1.37 Open:
AKBA Latest News
March 19, 2026 04:05:00 pm
Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
March 03, 2026 08:00:00 am
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
February 26, 2026 07:00:00 am
Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
AKBA Stock Data
$399,375,819
257,405,013
0.93%
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
